Varvil M, Clark S, Bailey T, Ramos-Vara J, Dos Santos A
J Vet Diagn Invest. 2023; 36(1):70-77.
PMID: 38014733
PMC: 10734577.
DOI: 10.1177/10406387231211908.
Buglyo G, Magyar Z, Romicsne Gorbe E, Banusz R, Csoka M, Micsik T
Med Sci Monit. 2021; 27:e932731.
PMID: 34608109
PMC: 8501895.
DOI: 10.12659/MSM.932731.
Siriwardhana C, Khadka V, Chen J, Deng Y
BMC Cancer. 2019; 19(1):34.
PMID: 30621620
PMC: 6325795.
DOI: 10.1186/s12885-018-5206-8.
Gao S, Zhao Z, Wu R, Wu L, Tian X, Zhang Z
Onco Targets Ther. 2018; 11:4837-4844.
PMID: 30147335
PMC: 6098416.
DOI: 10.2147/OTT.S169101.
Xu X, Liu H, Gross N, Wei D, Qian Y, Li W
Transl Oncol. 2018; 11(5):1244-1250.
PMID: 30103154
PMC: 6091437.
DOI: 10.1016/j.tranon.2018.07.018.
Training and validation of a novel 4-miRNA ratio model (MiCaP) for prediction of postoperative outcome in prostate cancer patients.
Schmidt L, Fredsoe J, Kristensen H, Strand S, Rasmussen A, Hoyer S
Ann Oncol. 2018; 29(9):2003-2009.
PMID: 30010760
PMC: 6158759.
DOI: 10.1093/annonc/mdy243.
Retrospective MicroRNA Sequencing: Complementary DNA Library Preparation Protocol Using Formalin-fixed Paraffin-embedded RNA Specimens.
Loudig O, Liu C, Rohan T, Ben-Dov I
J Vis Exp. 2018; (135).
PMID: 29781987
PMC: 6101110.
DOI: 10.3791/57471.
Differential microRNA expression in breast cancer with different onset age.
Tsai H, Huang S, Li C, Chien H, Chen S
PLoS One. 2018; 13(1):e0191195.
PMID: 29324832
PMC: 5764434.
DOI: 10.1371/journal.pone.0191195.
Fit for genomic and proteomic purposes: Sampling the fitness of nucleic acid and protein derivatives from formalin fixed paraffin embedded tissue.
Yakovleva A, Plieskatt J, Jensen S, Humeida R, Lang J, Li G
PLoS One. 2017; 12(7):e0181756.
PMID: 28742856
PMC: 5526578.
DOI: 10.1371/journal.pone.0181756.
Droplet Digital PCR versus qPCR for gene expression analysis with low abundant targets: from variable nonsense to publication quality data.
Taylor S, Laperriere G, Germain H
Sci Rep. 2017; 7(1):2409.
PMID: 28546538
PMC: 5445070.
DOI: 10.1038/s41598-017-02217-x.
Evaluation and Adaptation of a Laboratory-Based cDNA Library Preparation Protocol for Retrospective Sequencing of Archived MicroRNAs from up to 35-Year-Old Clinical FFPE Specimens.
Loudig O, Wang T, Ye K, Lin J, Wang Y, Ramnauth A
Int J Mol Sci. 2017; 18(3).
PMID: 28335433
PMC: 5372640.
DOI: 10.3390/ijms18030627.
miRNAs associated with prostate cancer risk and progression.
Luu H, Lin H, Sorensen K, Ogunwobi O, Kumar N, Chornokur G
BMC Urol. 2017; 17(1):18.
PMID: 28320379
PMC: 5359825.
DOI: 10.1186/s12894-017-0206-6.
Extracellular matrix gene expression profiling using microfluidics for colorectal carcinoma stratification.
Hayes C, Dowling C, Dwane S, McCumiskey M, Tormey S, Anne Merrigan B
Biomicrofluidics. 2016; 10(5):054124.
PMID: 27822332
PMC: 5097046.
DOI: 10.1063/1.4966245.
Association of tumour microRNA profiling with outcomes in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapy.
Bellmunt J, Zhou C, Mullane S, Werner L, Taplin M, Fay A
Br J Cancer. 2016; 115(1):12-9.
PMID: 27351382
PMC: 4931368.
DOI: 10.1038/bjc.2016.146.
MicroRNAs as potential biomarkers in cancer: opportunities and challenges.
Lan H, Lu H, Wang X, Jin H
Biomed Res Int. 2015; 2015:125094.
PMID: 25874201
PMC: 4385606.
DOI: 10.1155/2015/125094.
The potential of microRNAs in personalized medicine against cancers.
Saumet A, Mathelier A, Lecellier C
Biomed Res Int. 2014; 2014:642916.
PMID: 25243170
PMC: 4163464.
DOI: 10.1155/2014/642916.
Virus versus host plant microRNAs: who determines the outcome of the interaction?.
Maghuly F, Ramkat R, Laimer M
PLoS One. 2014; 9(6):e98263.
PMID: 24896088
PMC: 4045720.
DOI: 10.1371/journal.pone.0098263.
Critical appraisal of quantitative PCR results in colorectal cancer research: can we rely on published qPCR results?.
Dijkstra J, van Kempen L, Nagtegaal I, Bustin S
Mol Oncol. 2014; 8(4):813-8.
PMID: 24423493
PMC: 5528534.
DOI: 10.1016/j.molonc.2013.12.016.
Molecular markers for prostate cancer in formalin-fixed paraffin-embedded tissues.
Sequeiros T, Garcia M, Montes M, Olivan M, Rigau M, Colas E
Biomed Res Int. 2013; 2013:283635.
PMID: 24371818
PMC: 3859157.
DOI: 10.1155/2013/283635.
Personalized treatment for advanced colorectal cancer: KRAS and beyond.
Patel G, Karapetis C
Cancer Manag Res. 2013; 5:387-400.
PMID: 24294007
PMC: 3839845.
DOI: 10.2147/CMAR.S35025.